<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pulmo</journal-id><journal-title-group><journal-title xml:lang="ru">Пульмонология</journal-title><trans-title-group xml:lang="en"><trans-title>PULMONOLOGIYA</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0869-0189</issn><issn pub-type="epub">2541-9617</issn><publisher><publisher-name>Scientific and Practical Journal “PULMONOLOGIYA” LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18093/0869-0189-2016-26-2-196-200</article-id><article-id custom-type="elpub" pub-id-type="custom">pulmo-701</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Клубочковая фильтрация при бронхиальной астме: влияние адипокинов</article-title><trans-title-group xml:lang="en"><trans-title>Glomerular filtration rate in bronchial asthma: effects of adipokines</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Минеев</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Mineev</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д. м. н., профессор кафедры госпитальной терапии им. акад. М.В.Черноруцкого ГБОУ ВПО «Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П.Павлова» Минздрава России; тел.: (812) 450-71-63;</p></bio><bio xml:lang="en"><p>MD, Professor at M.V.Chernorutskiy Department of Hospital Internal Medicine, Academician I.P.Pavlov First Saint-Petersburg State Medical University, Healthcare Ministry of Russia; tel.: (812) 450-71-63;</p></bio><email xlink:type="simple">vnmineev@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Васильева</surname><given-names>Т. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Vasil'eva</surname><given-names>T. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к. м. н., врач общей практики Санкт-Петербургского ГБУЗ «Городская поликлиника № 34»; тел.: (950) 03-04-113;</p></bio><bio xml:lang="en"><p>PhD, General Practitioner at City State Outpatient Clinic No.34; tel.: (950) 030-41-13;</p></bio><email xlink:type="simple">tosa14@rambler.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лалаева</surname><given-names>Т. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Lalaeva</surname><given-names>T. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д. м. н., ассистент кафедры госпитальной терапии им. акад. М.В.Черноруцкого ГБОУ ВПО «Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П.Павлова» Минздрава России; тел.: (911) 912-89-43;</p></bio><bio xml:lang="en"><p>MD, Assistant Lecturer at M.V.Chernorutskiy Department of Hospital Internal Medicine, Academician I.P.Pavlov First Saint-Petersburg State Medical University, Healthcare Ministry of Russia; tel.: (911) 912-89-43;</p></bio><email xlink:type="simple">t.Lalaeva@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБОУ ВПО «Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П.Павлова» Минздрава России: 197022, Санкт-Петербург, ул. Льва Толстого, 6–8;</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Academician I.P.Pavlov First Saint-Petersburg State Medical University, Healthcare Ministry of Russia: 6 – 8, L'va Tolstogo str., Saint-Petersburg, 197022, Russia;</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Санкт-Петербургское ГБУЗ «Городская поликлиника № 34»: 197198, Санкт-Петербург, ул. Зверинская, 15</institution><country>Россия</country></aff><aff xml:lang="en"><institution>City State Outpatient Clinic No.34: 15, Zverinskaya str., Saint-Petersburg, 197198, Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>24</day><month>06</month><year>2016</year></pub-date><volume>26</volume><issue>2</issue><fpage>196</fpage><lpage>200</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Минеев В.Н., Васильева Т.С., Лалаева Т.М., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Минеев В.Н., Васильева Т.С., Лалаева Т.М.</copyright-holder><copyright-holder xml:lang="en">Mineev V.N., Vasil'eva T.S., Lalaeva T.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.pulmonology.ru/pulm/article/view/701">https://journal.pulmonology.ru/pulm/article/view/701</self-uri><abstract><p>Цель. Выявление взаимосвязи между экспрессией ключевых адипокинов при бронхиальной астме (БА) и скоростью клубочковой фильтрации (СКФ) при различных вариантах заболевания. Материалы и методы. Обследованы больные БА (n = 178) при различных ее вариантах. СКФ рассчитывалась по формуле Chronic Kidney Desease Epidemiology Collaboration (CKD-EPI). Содержание лептина, адипонектина, резистина, апелина в плазме крови определялась с помощью иммуноферментного метода (ELISA). Проведен корреляционный и факторный анализ с помощью программы SPSS для Windows, версия 13.0. Результаты. При БА выявлена корреляционная связь между СКФ, экспрессией ключевых адипокинов, а также экспрессией транскрипционного фактора phosphorylated signal transducer and activator of transcription-3, участвующего в трансдукции эффектов провоспалительных адипокинов. При этом выявленная негативная корреляционная связь между значениями расчетной СКФ и экспрессией адипокинов (лептин, резистин, адипонектин) в плазме характеризует преимущественно аллергический вариант БА. Заключение. Обсуждается возможная связь экспрессии ключевых адипокинов и фильтрационной активности почек при различных вариантах БА.</p></abstract><trans-abstract xml:lang="en"><p>The aim of the study was to analyze a relationship between key adipokines expression and the glomerular filtration rate (GFR) in different clinical variants of bronchial asthma (BA). Methods.We examined 178 patients with different clinical variants of BA. The glomerular filtration rate (eGFR) was estimated using CKD-EPI. Plasma concentrations of leptin, adiponectin, resistin, and apelin were measured using the ELISA method. Correlation and factor analyses were performed using the SPSS program for Windows, version 13.0. Results. A relationship between eGFR, key adipokines expression and pSTAT3 transcription factor expression, which is involved in proinflammatory adipokines effect transduction in BA, was found. Moreover, a reverse relationship between eGFR and adipokines (leptin, resistin, adiponectin) expression was mainly typical for allergic BA. Conclusion. Additional risk factors for development and progress of chronic renal disease are probably present in patients with BA even without obesity.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>бронхиальная астма</kwd><kwd>скорость клубочковой фильтрации</kwd><kwd>расчетная скорость клубочковой фильтрации по CKD-EPI</kwd><kwd>лептин</kwd><kwd>адипонектин</kwd><kwd>резистин</kwd><kwd>апелин</kwd></kwd-group><kwd-group xml:lang="en"><kwd>bronchial asthma</kwd><kwd>glomerular filtration rate</kwd><kwd>leptin</kwd><kwd>adiponectin</kwd><kwd>resistin</kwd><kwd>apelin</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Минеев В.Н., Трофимов В.И., Садовникова О.М. Бронхиальная астма и хроническая болезнь почек (об щие механизмы). Нефрология. 2015; 2: 27–32.</mixed-citation><mixed-citation xml:lang="en">Mineev V.N., Trofimov V.I., Sadovnikova O.M. Bronchial asthma and chronic renal disease: common mechanisms. Nefrologiya. 2015; 2: 27–32 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Teta D. Adipokines as uremic toxins. J. Ren Nutr. 2012; 22 (1): 81–85.</mixed-citation><mixed-citation xml:lang="en">HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Teta%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22200420" Teta D. Adipokines as uremic toxins. J.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/22200420" \o "Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation." Ren Nutr. 2012; 22 (1): 81–85.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Минеев В.Н., Зеленкова З.А., Садовникова О.М. Ско рость клубочковой фильтрации при различных вариан тах бронхиальной астмы. Пульмонология. 2015; 5: 593–599.</mixed-citation><mixed-citation xml:lang="en">Mineev V.N., Zelenkova Z.A., Sadovnikova O.M. Glomerular filtration rate in different variants of bronchial asthma. Pul'monologiya. 2015; 5: 593–599 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Минеев В.Н., Лалаева Т.М., Васильева Т.С., Кузьми на А.А. Лептин и адипонектин при бронхиальной аст ме. Цитокины и воспаление. 2015; 1: 68–75.</mixed-citation><mixed-citation xml:lang="en">Mineev V.N., Lalaeva T.M., Vasil'eva T.S., Kuz'mina A.A. Leptin and adiponectin in bronchial asthma. Tsitokiny i vospalenie. 2015; 1: 68–75 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Минеев В.Н., Лалаева Т.М., Кузьмина А.А. Ассоциация апелина 12, адипонектина, лептина и резистина при аллергической бронхиальной астме – использование интегральных индексов. Иммунопатология, аллергология, инфектология. 2015; 1: 30–34.</mixed-citation><mixed-citation xml:lang="en">Mineev V.N., Lalaeva T.M., Kuz'mina A.A. An association between apelin-12, adiponectin, leptin and resistin in allergic bronchial asthma: integral indexes. Immunopatologiya, allergologiya, infektologiya. 2015; 1: 30–34 (in Russian).Mineev V.N., Lalaeva T.M., Trofimov V.I. Adipokine signaling pathways in bronchial asthma. Saint-Petersburg: VVM; 2016 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Минеев В.Н., Лалаева Т.М., Трофимов В.И. Адипоки новая сигнализация при бронхиальной астме. СПб: ВВМ; 2016.</mixed-citation><mixed-citation xml:lang="en">Smirnov A.V., Shilov E.M., Dobronravov V.A. et al. National Guidelines on Chronic Renal Disease: Screening, Diagnosis, Prevention and Therapeutic Approaches. Saint-Petersburg: Levsha; 2012 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Смирнов А.В., Шилов Е.М., Добронравов В.А. и др. Национальные рекомендации. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. СПб: Левша; 2012.</mixed-citation><mixed-citation xml:lang="en">Mitsnefes M., Kartal J., Khoury P., Daniels S. Adiponectin in children with chronic kidney disease: role of adiposity and kidney dysfunction. Clin. J. Am. Soc. Nephrol. 2007; 2: 46–50.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mitsnefes M., Kartal J., Khoury P., Daniels S. Adiponectin in children with chronic kidney disease: role of adiposity and kidney dysfunction. Clin. J. Am. Soc. Nephrol. 2007; 2: 46–50.</mixed-citation><mixed-citation xml:lang="en">Guebre-Egziabher F., Bernhard J., Funahashi T. et al. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol. Dial. Transplant. 2005; 20: 129–134.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Guebre Egziabher F., Bernhard J., Funahashi T. et al. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol. Dial. Transplant. 2005; 20: 129–134.</mixed-citation><mixed-citation xml:lang="en">Miyamoto S., Sharma K. Adipokines protecting CKD. Nephrol. Dial. Transplant. 2013; 28 (Suppl. 4): iv15–iv22.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Miyamoto S., Sharma K. Adipokines protecting CKD. Nephrol. Dial. Transplant. 2013; 28 (Suppl. 4): iv15–iv22.</mixed-citation><mixed-citation xml:lang="en">Deshmukh S., Srivastava S., Bhardwaj A. et al. Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation. Oncotarget. 2015; 6 (13): 11231–11241.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Deshmukh S., Srivastava S., Bhardwaj A. et al. Resistin and interleukin 6 exhibit racially disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation. Oncotarget. 2015; 6 (13): 11231–11241.</mixed-citation><mixed-citation xml:lang="en">HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=Mafra%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18390566" Mafra D.,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=Guebre-Egziabher%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18390566" Guebre-Egziabher F.,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=Fouque%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18390566" Fouque D. Body mass index, muscle and fat in chronic kidney disease: questions about survival.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=Body+mass+index%2C+muscle+and+fat+in+chronic+kidney+disease%3A+questions+about+survival" \o "Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association." Nephrol. Dial. Transplant. 2008; 23 (8): 2461–2466.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Mafra D., Guebre Egziabher F., Fouque D. Body mass index, muscle and fat in chronic kidney disease: questions about survival. Nephrol. Dial. Transplant. 2008; 23 (8): 2461–2466.</mixed-citation><mixed-citation xml:lang="en">Mineev V. N., Lalaeva T. M., Vasil'eva T.S., Trofimov V.I. Asthma and obesity phenotype. Pul'monologiya. 2012; 2: 102–107 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Минеев В.Н., Лалаева Т.М., Васильева Т.С., Трофи мов В.И. Фенотип бронхиальной астмы с ожирением. Пульмонология. 2012; 2: 102–107.</mixed-citation><mixed-citation xml:lang="en">HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=Pandya%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25674175" Pandya D.,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=Puttanna%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25674175" Puttanna A.,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=Balagopal%20V%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25674175" Balagopal V. Systemic effects of inhaled corticosteroids: an overview.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/25674175" \o "The open respiratory medicine journal." Open Respir. Med. J. 2014; 8: 59–65.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Pandya D., Puttanna A., Balagopal V. Systemic effects of inhaled corticosteroids: an overview. Open Respir. Med. J. 2014; 8: 59–65.</mixed-citation><mixed-citation xml:lang="en">HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=Briffa%20JF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24107418" Briffa J.F.,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=McAinch%20AJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24107418" McAinch A.J.,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=Poronnik%20P%5BAuthor %5D&amp;cauthor=true&amp;cauthor_uid=24107418" Poronnik P.,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=Hryciw%20DH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24107418" Hryciw D.H. Adipokines as a link between obesity and chronic kidney disease.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/24107418" \o "American journal of physiology. Renal physiology." Am. J. Physiol. Renal Physiol. 2013; 305 (12): F1629–1636.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Briffa J.F., McAinch A.J., Poronnik P., Hryciw D.H. Adipo kines as a link between obesity and chronic kidney disease. Am. J. Physiol. Renal Physiol. 2013; 305 (12): F1629–1636.</mixed-citation><mixed-citation xml:lang="en">HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=R%C3%BCster%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24179016" Rüster C.,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=Wolf%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24179016" Wolf G. Adipokines promote chronic kidney disease.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/24179016" \o "Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association." Nephrol. Dial. Transplant. 2013; 28 (Suppl. 4): iv8–14.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Rüster C., Wolf G. Adipokines promote chronic kidney dis ease. Nephrol. Dial. Transplant. 2013; 28 (Suppl. 4): iv8–14.</mixed-citation><mixed-citation xml:lang="en">HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=Chuang%20PY%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20631733" Chuang P.Y.,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=He%20JC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20631733" He J.C. JAK/STAT signaling in renal diseases.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/20631733" \o "Kidney international." Kidney Int. 2010; 78 (3): 231–234.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Chuang P.Y., He J.C. JAK/STAT signaling in renal diseases. Kidney Int. 2010; 78 (3): 231–234.</mixed-citation><mixed-citation xml:lang="en">Mineev V.N., Sorokina L.N., Trofimov V.I. Fundamental and clinical aspects of JAK-STAT signaling pathways. Saint-Petersburg: BBM; 2010 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Минеев В.Н., Сорокина Л.Н., Трофимов В.И. Фундаментальные и клинические аспекты JAK STAT сигнализации. СПб: BBM; 2010.</mixed-citation><mixed-citation xml:lang="en">HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=Pang%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20520592" Pang M.,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=Ma%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20520592" Ma L.,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=Gong%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20520592" Gong R. et al. A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/20520592" \o "Kidney international." Kidney Int. 2010; 78 (3): 257–268.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Pang M., Ma L., Gong R. et al. A novel STAT3 inhibitor, S3I 201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy. Kidney Int. 2010; 78 (3): 257–268.</mixed-citation><mixed-citation xml:lang="en">HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=Brosius%20FC%203rd%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25415616" Brosius F.C. 3rd,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=He%20JC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25415616" He J.C. JAK inhibition and progressive kidney disease.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/25415616" \o "Current opinion in nephrology and hypertension." Curr. Opin. Nephrol. Hypertens. 2015; 24 (1): 88–95.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Brosius F.C. 3rd, He J.C. JAK inhibition and progressive kid ney disease. Curr. Opin. Nephrol. Hypertens. 2015; 24 (1): 88–95.</mixed-citation><mixed-citation xml:lang="en">Brosius F.C. 3rd, He J.C. JAK inhibition and progressive kid ney disease. Curr. Opin. Nephrol. Hypertens. 2015; 24 (1): 88–95.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
